Discover 72 paid clinical trials in Bangor, Maine. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.
Filter
2
Filter results
Results: 72
Active & Responsive
The CDK4/6 Inhibitor Dosing Knowledge (CDK) Study
for
Metastatic Breast Cancer
Location: Brewer ME, Augusta ME, Methuen MA, Boston MA, Weymouth MA,
Sponsor: American Society of Clinical Oncology
Sex: All
Age: 65+
Code: NCT06377852
Phase3, Recruiting
Micronutrients as Adjunctive Treatment for Bipolar Disorder
for
Bipolar Disorder
Location: Bangor ME
Sponsor: Eastern Maine Medical Center
Sex: All
Age: 18+
Code: NCT03541031
Recruiting
Biomarkers in Tumor Tissue Samples From Patients With Newly Diagnosed Neuroblastoma or Ganglioneuroblastoma
Get alerts for new trials in your area by subscribing now
By submitting, you consent to the use of your personal details, including contact information and location, to respond to your request for information related to clinical trials, as outlined in the Privacy Policy. If at any time you want to discontinue receiving alerts, please click the Unsubscribe link in the email received.
A Study of the Drug Selinexor With Radiation Therapy in Patients With Newly-Diagnosed Diffuse Intrinsic Pontine (DIPG) Glioma and High-Grade Glioma (HGG)
for
Malignant Glioma
Location: Bangor ME, Scarborough ME, Boston MA, Providence RI,
Sponsor: National Cancer Institute (NCI)
Sex: All
Age: 12 - 21
Code: NCT05099003
Phase1, Phase2, Recruiting
A Study of Remternetug (LY3372993) in Early Alzheimer's Disease (TRAILRUNNER-ALZ 3)
for
Alzheimer's Disease
Location: Bangor ME, Sherbrooke, Victoriaville, Levis, Quebec, Boston MA,
Sponsor: Eli Lilly and Company
Sex: All
Age: 55 - 70+
Code: NCT06653153
Phase3, Recruiting
Efficacy of Dupilumab Added to Medium Dose Inhaled Corticosteroid/Long-acting Beta-agonist (ICS/LABA) in Comparison to ICS Dose Escalation to High Dose ICS/LABA in Adolescent and Adult Patients With Uncontrolled Asthma
for
Asthma
Location: Bangor ME, Quebec, Dover MA, Hawthorne NY, New York NY,
Sponsor: Regeneron Pharmaceuticals
Sex: All
Age: 12 - 70+
Code: NCT06572228
Recruiting
Inotuzumab Ozogamicin in Treating Younger Patients With B-Lymphoblastic Lymphoma or Relapsed or Refractory CD22 Positive B Acute Lymphoblastic Leukemia
for
Recurrent B Acute Lymphoblastic Leukemia,
Location: Bangor ME, Scarborough ME, Lebanon NH, Boston MA,
Sponsor: Children's Oncology Group
Sex: All
Age: 1 - 21
Code: NCT02981628
Phase2, Recruiting
Effect of Dalcetrapib on CV Risk in a Genetically Defined Population With a Recent ACS